Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2
Morag J. Young, Colin D. Clyne, Karen E. Chapman
Journal of Endocrinology (2020) Vol. 247, Iss. 2, pp. R45-R62
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

COVID-19 and metabolic disease: mechanisms and clinical management
Charlotte Steenblock, Peter E. H. Schwarz, Barbara Ludwig, et al.
The Lancet Diabetes & Endocrinology (2021) Vol. 9, Iss. 11, pp. 786-798
Open Access | Times Cited: 206
miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19
Alessandro Matarese, Jessica Gambardella, Celestino Sardu, et al.
Biomedicines (2020) Vol. 8, Iss. 11, pp. 462-462
Open Access | Times Cited: 128
Association between pharmaceutical modulation of oestrogen in postmenopausal women in Sweden and death due to COVID-19: a cohort study
Malin Sund, Osvaldo Fonseca‐Rodríguez, Andreas Josefsson, et al.
BMJ Open (2022) Vol. 12, Iss. 2, pp. e053032-e053032
Open Access | Times Cited: 40
Mineralocorticoid receptor and glucocorticoid receptor work alone and together in cell-type-specific manner: Implications for resilience prediction and targeted therapy
Nikolaos P. Daskalakis, Onno C. Meijer, E. R. de Kloet
Neurobiology of Stress (2022) Vol. 18, pp. 100455-100455
Open Access | Times Cited: 37
Approaches towards fighting the COVID‑19 pandemic (Review)
Shih‐Chang Tsai, Chi‐Cheng Lu, DA-TIAN BAU, et al.
International Journal of Molecular Medicine (2020) Vol. 47, Iss. 1, pp. 3-22
Open Access | Times Cited: 67
ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease
Jithin Kuriakose, Augusto C. Montezano, Rhian M. Touyz
Clinical Science (2021) Vol. 135, Iss. 2, pp. 387-407
Open Access | Times Cited: 50
The Physiological Mechanisms of the Sex-Based Difference in Outcomes of COVID19 Infection
Susan Wray, Sarah Arrowsmith
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 46
IL-6 modulation for COVID-19: the right patients at the right time?
Paolo A. Ascierto, Binqing Fu, Haiming Wei
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 4, pp. e002285-e002285
Open Access | Times Cited: 46
Pilot Findings on SARS-CoV-2 Vaccine-Induced Pituitary Diseases: A Mini Review from Diagnosis to Pathophysiology
Taïeb Ach, M. El Euch
Vaccines (2022) Vol. 10, Iss. 12, pp. 2004-2004
Open Access | Times Cited: 27
Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment
Mark C. Chappell
Circulation Research (2023) Vol. 132, Iss. 10, pp. 1320-1337
Open Access | Times Cited: 17
SARS-CoV-2-induced Overexpression of miR-4485 Suppresses Osteogenic Differentiation and Impairs Fracture Healing
Bobin Mi, Yuan Xiong, Chenming Zhang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 5, pp. 1277-1288
Open Access | Times Cited: 39
Regulation of vascular angiotensin II type 1 and type 2 receptor and angiotensin-(1–7)/MasR signaling in normal and hypertensive pregnancy
Caroline R. Clark, Raouf A. Khalil
Biochemical Pharmacology (2023) Vol. 220, pp. 115963-115963
Open Access | Times Cited: 13
Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
Tommaso Piticchio, Rosario Le Moli, D. Tumino, et al.
Journal of Endocrinological Investigation (2021) Vol. 44, Iss. 8, pp. 1553-1570
Open Access | Times Cited: 30
SARS-CoV-2 Infection and Preeclampsia—How an Infection Can Help Us to Know More about an Obstetric Condition
Otilia Gonzalez, Óscar Martínez Pérez
Viruses (2023) Vol. 15, Iss. 7, pp. 1564-1564
Open Access | Times Cited: 11
COVID‑19‑related thyroid conditions (Review)
Florica Șandru, Mara Carşote, Răzvan Petca, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 26
Clinical course and outcome of patients with ACTH-dependent Cushing’s syndrome infected with novel coronavirus disease-19 (COVID-19): case presentations
Zhanna Belaya, Olga O. Golounina, G. А. Melnichenko, et al.
Endocrine (2021) Vol. 72, Iss. 1, pp. 12-19
Open Access | Times Cited: 24
Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs
Suvasmita Rath, Venkateswarlu Perikala, Atala Bihari Jena, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 143, pp. 112095-112095
Open Access | Times Cited: 21
A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection
Savannah M. Rocha, Anna C. Fagre, Amanda S. Latham, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Calcifediol or Corticosteroids in the Treatment of COVID-19: An Observational Study
Marta Entrenas Castillo, Luis Manuel Entrenas Costa, María P. Pata, et al.
Nutrients (2024) Vol. 16, Iss. 12, pp. 1910-1910
Open Access | Times Cited: 2
Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice
Radu Crișan-Dabija, Ileana Antohe, Antigona Trofor, et al.
Expert Review of Anti-infective Therapy (2021) Vol. 19, Iss. 12, pp. 1553-1562
Open Access | Times Cited: 18
Possible harm from glucocorticoid drugs misuse in the early phase of SARS-CoV-2 infection: a narrative review of the evidence
Riccardo Sarzani, Francesco Spannella, Federico Giulietti, et al.
Internal and Emergency Medicine (2021) Vol. 17, Iss. 2, pp. 329-338
Open Access | Times Cited: 18
Glucose metabolism disorder: a potential accomplice of SARS-CoV-2
Yi Luan, Ying Luan, Hongbo He, et al.
International Journal of Obesity (2023) Vol. 47, Iss. 10, pp. 893-902
Closed Access | Times Cited: 7
Expression of SARS-CoV-2 receptor “ACE2” in human pancreatic β cells: to be or not to be!
Waseem El‐Huneidi, Mawieh Hamad, Jalal Taneera
Islets (2021) Vol. 13, Iss. 5-6, pp. 106-114
Open Access | Times Cited: 15
SARS Cov2 Infection and Preeclampsia. How an Infection Can Help Us To Know More About an Obstetric Condition
Otilia Gonzalez, Óscar Martínez Pérez
(2023)
Open Access | Times Cited: 5
Effect of the renin–angiotensin–aldosterone system inhibitors on time to nucleic acid negative conversion in hypertensive patients with SARS-CoV-2 omicron infection: a propensity score matching study
Ru Wen, Jinwen Li, Fengxi Chen, et al.
Hypertension Research (2024) Vol. 48, Iss. 1, pp. 273-283
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top